iguratimod antiinflammatory small molecule drug used treatment rheumatoid arthritis together methotrexate japan biological target known prevents nfÎºb activation subsequently selectively inhibits several inflammatory adverse effects include elevated transaminases nausea vomiting stomach pain rashes derivative chromone two amide groups first published submitted regulatory approval japan application withdrawn resubmitted additional data approved marketing japan eisai toyama chemical market approval obtained china simcere independently japanese discovery development called marketed names careram antineoplastic immunomodulatory drug article stub help wikipedia expanding httpsenwikipediaorgwikiiguratimod